In addition, in contrast to previous studies, enhancer strength did not correlate with chromatin state, as the functionally potent TT>A enhancer linked with autoimmune diseases exhibited relatively low chromatin accessibility (Figs. 1b and 5a), although this enhancer does show substantial TF binding in various cell types (Supplementary Fig. 14). This evidence concerns the gene TF and autoimmune disease.